Kamagata, Eiichiro <br/><br/>
Improvements in Quality-Adjusted Life Years and Cost-Utility After Pharmacotherapy for Premenstrual Dysphoric Disorder: A Retrospective Study.  [electronic resource] 

 -  Clinical drug investigation  Jan 2018 
 - 49-55 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1179-1918 
<br/><br/><label>Standard No.: </label>10.1007/s40261-017-0583-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Citalopram--economics<br/>Cost-Benefit Analysis<br/>Female<br/>Humans<br/>Middle Aged<br/>Premenstrual Dysphoric Disorder--drug therapy<br/>Quality-Adjusted Life Years<br/>Retrospective Studies<br/>Sertraline--economics<br/>Young Adult